Why does airway inflammation persist? Is it leukotrienes?

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 3 II, 2000, Pages

  O'Byrne, Paul M ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PHOSPHOLIPASE A;

ASTHMA; BRONCHOSPASM; CHRONIC INFLAMMATION; CONFERENCE PAPER; DRUG RESPONSE; HUMAN; LUNG LAVAGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION;

EID: 0034027127     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.supplement_2.a1q4-8     Document Type: Conference Paper

References (28)

1. Manning, P. J., J. Rokach, J. L. Malo, D. Ethier, A. Cartier, Y. Girard, S. Charleson, and P. M. O'Byrne. 1990. Urinary leukotriene E4 levels during early and late asthmatic responses. J. Allergy Clin. Immunol. 86:211-220.
2. Taylor, G. W., P. Black, N. Turner, I. Taylor, N. H. Maltby, R. W. Fuller, and C. T. Dollery. 1989. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet i:585-587.
3. Dahlén, B., M. Kumlin, H. Johannson, C. Larsson, O. Zetterström, E. Granström, and S.-E. Dahlén. 1991. Aspirin-sensitive asthmatics have elevated basal levels of leukotriene E4 in urine and bronchial provocation with lysine-aspirin results in further release. Am. Rev. Respir. Dis. 143:599-604.
4. Cowburn, A. S., K. Sladek, J. Soja, L. Adamek, E. Nizankowska, A. Szczeklik, B. K. Lam, J. F. Penrose, K. F. Austen, S. T. Holgate, and A. P. Sampson. 1999. Overexpression of leukotriene C4 synthetase in bronchial biopsies from patients with aspirin-intolerant asthma. J. Clin. Invest. 101:834-846.
5. Taylor, I. K., K. M. O'Shaughnessy, R. W. Fuller, and C. T. Dollery. 1991. Effect of a cysteinylleukotriene receptor antagonist, ICI 204-209, on allergen-induced bronchoconstriction and airway hyperactivity in atopic subjects. Lancet 337:690-694.
6. Israel, E., A. R. Fischer, M. A. Rosenburg, C. M. Lilly, J. C. Callery, J. Shapiro, J. Cohn, P. Rubin, and J. Drazen. 1993. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am. Rev. Respir. Dis. 148:1447-1451.
7. Manning, P. J., R. M. Watson, D. J. Margolskee, V. C. Williams, J. I. Schwartz, and P. M. O'Byrne. 1990. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N. Engl. J. Med. 323:1736-1739.
8. Hamilton, A. L., I. Faiferman, P. Stober, R. M. Watson, and P. M. O'Byrne. 1998. Pranlukast, a leukotriene receptor antagonist, attenuates allergen-induced early and late phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. J. Allergy Clin. Immunol. 102:177-183.
9. Hui, K. P., and N. C. Barnes. 1991. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist. Lancet 337:1062-1063.
10. Gaddy, J., R. K. Bush, D. Margolskee, V. C. Williams, and W. Busse. 1992. The effects of leukotriene D4 (LTD4) antagonist (MK-571) in mild to moderate asthma. Am. Rev. Respir. Dis. 146:358-363.
11. Israel, E., P. Rubin, J. P. Kemp, J. Grossman, W. Pierson, S. C. Siegel, D. Tinkelman, J. J. Murray, W. W. Busse, and A. T. Segal. 1993. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann. Intern. Med. 119:1059-1066.
12. Spada, C. S., A. L. Nieves, A. H. Krauss, and D. F. Woodward. 1994. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. J. Leukocyte Biol. 55:183-191.
13. Laitinen, L. A., A. Laitinen, T. Haahtela, V. Vikka, B. W. Spur, and T. H. Lee. 1993. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 341:989-990.
14. Diamant, Z., J. T. Hiltermann, E. L. J. van Rensen, P. M. C. Callenbach, M. A. Veselic-Charvat, H. van der Veen, and P. Sterk. 1997. The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma. Am. J. Respir. Crit. Care Med. 155:1247-1253.
15. 4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects. Am. J. Respir. Crit. Care Med. 159:1562-1567.
16. Kane, G. C., M. Polloce, C. J. Kim, R. T. Dworski, J. J. Murray, J. R Sheller, J. E. Fish, and S. P. Peters. 1996. A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings. J. Allergy Clin. Immunol. 97:646-654.
17. Calhoun, W. J., B. J. Lavins, M. C. Minkwitz, R. Evans, G. J. Gleich, and J. Cohn. 1998. Effect of Zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental allergen challenge. Am. J. Respir. Crit. Care Med. 157:1381-1389.
18. Wenzel, S. E., J. B. Trudeau, D. A. Kaminsky, J. Cohn, R. J. Martin, and J. Y. Westcott. 1995. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am. J. Respir. Crit. Care Med. 152:897-905.
19. Malstrom, K., G. Rodriguez Gomez, J. Guerra, C. Villaran, A. Piñeiro, L. X. Wei, B. C. Seidenberg, and T. F. Reiss. 1999. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann. Intern. Med. 130:487-495.
20. Knorr, B., J. Matz, J. A. Bernstein, H. Nguyen, B. C. Seidenberg, T. Reiss, and A. Becker. 1998. Montelukast for chronic asthma in 60 to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. J.A.M.A. 279:1181-1186.
21. Pizzichini, E., J. A. Leff, T. Reiss, L. Hendeles, L. P. Boulet, L. X. Wei, A. Efthimiadis, J. Zhang, and F. E. Hargreave. 1999. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur. Respir. J. (In press)
22. Sampson, A. P., D. P. Castling, C. P. Green, and J. F. Price. 1995. Persistent increase in plasma and urinary leukotrienes after acute asthma. Arch. Dis. Child. 73:221-225.
23. Shindo, K., M. Fukumura, and K. Miyakawa. 1995. Leukotriene B4 levels in the arterial blood of asthmatic patients and the effects of prednisolone. Eur. Respir. J. 8:605-610.
24. Wenzel, S. E., S. J. Szefler, D. Y. M. Leung, S. I. Sloan, M. D. Rex, and R. J. Martin. 1997. Bronchoscopic evaluation of severe asthma: persistent inflammation despite high dose glucocorticosteroids. Am. J. Respir. Crit. Care Med. 156:737-743.
25. Wenzel, S. E., J. B. Trudeau, J. Y. Westcott, W. R. Beam, and R. J. Martin. 1994. A single oral dose of prednisone decreases leukotriene B4 production by alveolar macrophages from patients with nocturnal asthma but not control subjects: relationship to changes in cellular influx and FEVI. J. Allergy Clin. Immunol. 94:870-881.
26. Sampson, S. E., J. F. Costello, and A. P. Sampson. 1997. The effect of inhaled leukotriene B4 in normal and asthmatic subjects. Am. J. Respir. Crit. Care Med. 155:1789-1792.
27. 4 receptor antagonist LY293111, on allergen-induced responses in asthma. Thorax 51:1178-1184.
28. Turner, M. O., P. Hussack, M. R. Sears, J. Dolovich, and F. E. Hargreave. 1995. Exacerbations of asthma without sputum eosinophilia. Thorax 50:1057-1061.